Why IBD 50's Top Seed, Hims & Hers, Just Crashed On Its Upbeat Earnings
In This Article:
Hims stock plunged Tuesday after the compounding pharmacy issued a bullish outlook that still includes knockoff versions of semaglutide.
Oops, something went wrong
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Hims stock plunged Tuesday after the compounding pharmacy issued a bullish outlook that still includes knockoff versions of semaglutide.